Â
Latest Diastematomyelia Companies Update
Brainlab AG Introduced the iPlan Cranial 3D software with advanced segmentation tools for visualizing and analyzing diastematomyelia, facilitating preoperative planning and surgical simulation.
Medtronic Developed the StealthVizâ„¢ Surgical Navigation System with the ability to integrate intraoperative MRI data, allowing for real-time visualization of neural structures during diastematomyelia surgery, improving accuracy and safety.
Karl Storz GmbH & Co. KG Launched minimally invasive surgical instruments specifically designed for diastematomyelia repair, minimizing tissue damage and promoting faster recovery for patients.
Johnson & Johnson Acquired Auris Surgical Robotics, a company developing robotic-assisted surgery platforms, potentially impacting the future of minimally invasive diastematomyelia repair.
Stryker Corporation Partnered with academic institutions to research and develop innovative biocompatible materials for spinal cord reconstruction after diastematomyelia surgery.
Boston Scientific Corporation Collaborated with neurosurgeons to refine surgical techniques and optimize treatment protocols for diastematomyelia, aiming to improve long-term outcomes for patients.
List of Diastematomyelia Key Companies in the Market
- 3M (US)
- GlaxoSmithKline PLC (U.K)
- Pfizer Inc. (U.S.)
- Lineage Medical Inc. (U.S.)
- Johnson & Johnson Services Inc. (U.S.)
- Bristol-Myers Squibb and Company (U.S.)
- Braun (Germany)
- Stryker Corporation (U.S.)
- Argon Medical Devices Inc (the Netherlands)
- Cook Medical (U.S.)